Chronic Myelogenous Leukemia (CML) Latest Advances
Find the Latest Research About Chronic Myelogenous Leukemia (CML)
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26354 publications
Revisiting Asciminib Resistance: From Binding Affinity to Allosteric Disruption in BCR::ABL1 Leukemias.
Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology
Published: September 08, 2026
Inter-laboratory comparison of international standardized BCR::ABL1 (P210) mRNA of chronic myeloid leukemia patients by digital PCR
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: September 07, 2026
Evaluation of BCR::ABL1 Positivity in Peripheral Blood Neutrophils Enables the Diagnosis of De Novo Blast Phase Chronic Myeloid Leukemia with Additional Structural Abnormalities of the Philadelphia Chromosome.
Journal: Internal medicine (Tokyo, Japan)
Published: September 02, 2026
Thiotepa-busulfan-fludarabine conditioning in allogeneic hematopoietic stem cell transplantation for blast-phase myeloproliferative neoplasm
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: August 30, 2026
Predictors of treatment-free remission (TFR) and second TFR attempts in chronic myeloid leukemia
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: August 30, 2026
Chronic-phase chronic myeloid leukemia complicated by dasatinib-associated lymphadenopathy
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: August 30, 2026
Editor's Note: Targeting Primitive Chronic Myeloid Leukemia Cells by Effective Inhibition of a New AHI-1-BCR-ABL-JAK2 Complex.
Journal: Journal of the National Cancer Institute
Published: August 27, 2026
CD7 CAR-T cells eliminate chronic myeloid leukemia stem cells specifically and effectively.
Journal: Hematology (Amsterdam, Netherlands)
Published: August 22, 2026
Evaluation of hypomethylating agents with or without venetoclax in patients with accelerated phase and blast phase myeloproliferative neoplasms: a HERO consortium study.
Journal: Leukemia & lymphoma
Published: August 20, 2026
Dasatinib-induced cervicofacial oedema in chronic myeloid leukaemia blast crisis.
Journal: BMJ case reports
Published: August 19, 2026
Corrigendum to "Hyperoside impairs mitochondrial respiration in chronic myeloid leukemia by promoting STUB1-mediated ubiquitination and degradation of NOX4" [Toxicology and Applied Pharmacology 511 (2026) 117795].
Journal: Toxicology and applied pharmacology
Published: August 17, 2026
Nilotinib in chronic myeloid leukemia: clinical value, real-world challenges, and the potential of nilotinib tablets to improve therapeutic outcomes.
Journal: Expert review of hematology
Published: August 12, 2026
Last Updated: 09/26/2026